CelluJuve® for the Treatment of Moderate to Severe NLFs

NCT07545980 · clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Spiderwort Biotechnologies Inc.